
Title:
Ibuprofen
Text:
.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}"Profen" redirects here. For the municipal district in Germany, see Elsteraue.
Medication used for treating pain, fever, and inflammation


.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}IbuprofenClinical dataPronunciation/ˈaɪbjuːproʊfɛn/, /aɪbjuːˈproʊfən/, EYE-bew-PROH-fən Trade namesAdvil, Motrin, Nurofen, othersOther namesisobutylphenylpropionic acidAHFS/Drugs.comMonographMedlinePlusa682159License data
EU EMA: by INN
US DailyMed: Ibuprofen
US FDA: Ibuprofen
Pregnancycategory
AU: C[1]

Routes ofadministrationBy mouth, rectal, topical, intravenousATC codeC01EB16 (WHO) G02CC01 (WHO) M01AE01 (WHO) M02AA13 (WHO) R02AX02 (WHO)Legal statusLegal status
AU: OTC 
CA: OTC 
UK: General sales list (GSL, OTC) 
US: OTC / Rx-only
Pharmacokinetic dataBioavailability80–100% (by mouth),[2] 87% (rectal)Protein binding98%[3]MetabolismLiver (CYP2C9)[3]Metabolitesibuprofen glucuronide, 2-hydroxyibuprofen, 3-hydroxyibuprofen, carboxy-ibuprofen, 1-hydroxyibuprofenOnset of action30 min[4]Elimination half-life2–4 h[5]ExcretionUrine (95%)[3][6]Identifiers
IUPAC name
(RS)-2-(4-(2-Methylpropyl)phenyl)propanoic acid
CAS Number15687-27-1 YPubChem CID3672IUPHAR/BPS2713DrugBankDB01050 YChemSpider3544 YUNIIWK2XYI10QMKEGGD00126 YChEBICHEBI:5855 YChEMBLChEMBL521 YPDB ligandIBP (PDBe, RCSB PDB)CompTox Dashboard (EPA)DTXSID5020732 ECHA InfoCard100.036.152 Chemical and physical dataFormulaC13H18O2Molar mass206.285 g·mol−13D model (JSmol)Interactive imageChiralityRacemic mixtureDensity1.03 g/cm3Melting point75 to 78 °C (167 to 172 °F)Boiling point157 °C (315 °F) at 4 mmHgSolubility in water0.021 mg/mL (20 °C)
SMILES
CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)O

InChI
InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15) YKey:HEFNNWSXXWATRW-UHFFFAOYSA-N Y
.mw-parser-output .nobold{font-weight:normal}  (verify)
Ibuprofen is a medication in the nonsteroidal anti-inflammatory drug (NSAID) class that is used for treating pain, fever, and inflammation.[7] This includes painful menstrual periods, migraines, and rheumatoid arthritis.[7] It may also be used to close a patent ductus arteriosus in a premature baby.[7] It can be used by mouth or intravenously.[7] It typically begins working within an hour.[7]
Common side effects include heartburn and a rash.[7] Compared to other NSAIDs, it may have other side effects such as gastrointestinal bleeding.[8] It increases the risk of heart failure, kidney failure, and liver failure.[7] At low doses, it does not appear to increase the risk of heart attack; however, at higher doses it may.[8] Ibuprofen can also worsen asthma.[8] While it is unclear whether it is safe in early pregnancy,[7] it appears to be harmful in later pregnancy and therefore is not recommended.[9] Like other NSAIDs, it works by inhibiting the production of prostaglandins by decreasing the activity of the enzyme cyclooxygenase (COX).[7] Ibuprofen is a weaker anti-inflammatory agent than other NSAIDs.[8]
Ibuprofen was discovered in 1961 by Stewart Adams and John Nicholson[10] while working at Boots UK Limited and initially marketed as Brufen.[11] It is available under a number of trade names, including Nurofen, Advil and Motrin.[7][12] It was first marketed in 1969 in the United Kingdom and in 1974 in the United States.[7][11] 
It is on the World Health Organization's List of Essential Medicines.[13] It is available as a generic medication.[7] In 2019, it was the 29th most commonly prescribed medication in the United States, with more than 21 million prescriptions.[14][15]

.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}Contents

1 Medical uses

1.1 Lysine


2 Adverse effects

2.1 Cardiovascular risk
2.2 Skin
2.3 Interactions

2.3.1 Alcohol
2.3.2 Aspirin
2.3.3 Paracetamol


2.4 Overdose
2.5 Miscarriage


3 Pharmacology

3.1 Pharmacokinetics


4 Chemistry

4.1 Stereochemistry


5 History
6 Society and culture

6.1 Availability
6.2 Route


7 Research

7.1 COVID‑19


8 References
9 External links



Medical uses[edit]
  Example of some 200 mg ibuprofen tablets
Ibuprofen is used primarily to treat fever (including post-vaccination fever), mild to moderate pain (including pain relief after surgery), painful menstruation, osteoarthritis, dental pain, headaches, and pain from kidney stones. About 60% of people respond to any NSAID; those who do not respond well to a particular one may respond to another.[16]
It is used for inflammatory diseases such as juvenile idiopathic arthritis and rheumatoid arthritis.[17][18] It is also used for pericarditis and patent ductus arteriosus.[19][20]
If a patient is self-treating with over-the-counter Ibuprofen, it should not be taken for more than 10 days, unless the patient has spoken with his/her doctor.[21]

Lysine[edit]
In some countries, ibuprofen lysine (the lysine salt of ibuprofen, sometimes called "ibuprofen lysinate") is licensed for treatment of the same conditions as ibuprofen; the lysine salt is used because it is more water-soluble.[22] 
Ibuprofen lysine is being sold for rapid pain relief[23] because, given in form of a lysine salt, absorption is much quicker (35 minutes compared to 90–120 minutes). However, a clinical trial with 351 participants in 2020, which was funded by Sanofi, found that there is no significant difference between ibuprofen and ibuprofen lysine concerning the eventual onset of action or analgesic efficacy.[24][unreliable medical source]
In 2006, ibuprofen lysine was approved in the U.S. by the Food and Drug Administration (FDA) for closure of patent ductus arteriosus in premature infants weighing between 500 and 1,500 g (1 and 3 lb), who are no more than 32 weeks' gestational age when usual medical management (such as fluid restriction, diuretics, and respiratory support) is not effective.[25]

Adverse effects[edit]
Adverse effects include nausea, dyspepsia, diarrhea, constipation, gastrointestinal ulceration/bleeding, headache, dizziness, rash, salt and fluid retention, and high blood pressure.[18][26]
Infrequent adverse effects include esophageal ulceration, heart failure, high blood levels of potassium, kidney impairment, confusion, and bronchospasm.[18] Ibuprofen can exacerbate asthma, sometimes fatally.[27]
Allergic reactions, including anaphylaxis and anaphylactic shock, may occur.[28] Ibuprofen may be quantified in blood, plasma, or serum to demonstrate the presence of the drug in a person having experienced an anaphylactic reaction, confirm a diagnosis of poisoning in people who are hospitalized, or assist in a medicolegal death investigation. A monograph relating ibuprofen plasma concentration, time since ingestion, and risk of developing renal toxicity in people who have overdosed has been published.[29]
In October 2020, the U.S. Food and Drug Administration (FDA) required the drug label to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in unborn babies that result in low amniotic fluid.[30][31] They recommend avoiding NSAIDs in pregnant women at 20 weeks or later in pregnancy.[30][31]

Cardiovascular risk[edit]
Along with several other NSAIDs, chronic ibuprofen use has been found correlated with risk of progression to hypertension in women, though less than for acetaminophen,[32] and myocardial infarction (heart attack),[33] particularly among those chronically using higher doses. On 9 July 2015, the U.S. Food and Drug Administration (FDA) toughened warnings of increased heart attack and stroke risk associated with ibuprofen and related NSAIDs; the NSAID aspirin is not included in this warning.[34] The European Medicines Agency (EMA) issued similar warnings in 2015.[35][36]

Skin[edit]
Along with other NSAIDs, ibuprofen has been associated with the onset of bullous pemphigoid or pemphigoid-like blistering.[37] As with other NSAIDs, ibuprofen has been reported to be a photosensitising agent,[38] but it is considered a weak photosensitising agent compared to other members of the 2-arylpropionic acid class. Like other NSAIDs, ibuprofen is an extremely rare cause of the autoimmune disease Stevens–Johnson syndrome (SJS).[39][40] Ibuprofen is also an extremely rare cause of toxic epidermal necrolysis.[41]

Interactions[edit]
Alcohol[edit]
Drinking alcohol when taking ibuprofen may increase the risk of stomach bleeding.[42]

Aspirin[edit]
According to the Food and Drug Administration (FDA), "ibuprofen can interfere with the antiplatelet effect of low-dose aspirin, potentially rendering aspirin less effective when used for cardioprotection and stroke prevention". Allowing sufficient time between doses of ibuprofen and immediate-release (IR) aspirin can avoid this problem. The recommended elapsed time between a dose of ibuprofen and a dose of aspirin depends on which is taken first. It would be 30 minutes or more for ibuprofen taken after IR aspirin, and 8 hours or more for ibuprofen taken before IR aspirin. However, this timing cannot be recommended for enteric-coated aspirin. But, if ibuprofen is taken only occasionally without the recommended timing, the reduction of the cardioprotection and stroke prevention of a daily aspirin regimen is minimal.[43]

Paracetamol[edit]
Ibuprofen combined with paracetamol is considered generally safe in children for short-term usage.[44]

Overdose[edit]
Ibuprofen overdose has become common since it was licensed for OTC use. Many overdose experiences are reported in the medical literature, although the frequency of life-threatening complications from ibuprofen overdose is low.[45] Human response in cases of overdose ranges from an absence of symptoms to a fatal outcome despite intensive-care treatment. Most symptoms are an excess of the pharmacological action of ibuprofen, and include abdominal pain, nausea, vomiting, drowsiness, dizziness, headache, ear ringing, and nystagmus. Rarely, more severe symptoms, such as gastrointestinal bleeding, seizures, metabolic acidosis, high blood levels of potassium, low blood pressure, slow heart rate, fast heart rate, atrial fibrillation, coma, liver dysfunction, acute kidney failure, cyanosis, respiratory depression, and cardiac arrest have been reported.[46] The severity of symptoms varies with the ingested dose and the time elapsed; however, individual sensitivity also plays an important role. Generally, the symptoms observed with an overdose of ibuprofen are similar to the symptoms caused by overdoses of other NSAIDs.
Correlation between severity of symptoms and measured ibuprofen plasma levels is weak. Toxic effects are unlikely at doses below 100 mg/kg, but can be severe above 400 mg/kg (around 150 tablets of 200 mg units for an average man);[47] however, large doses do not indicate the clinical course is likely to be lethal.[48] A precise lethal dose is difficult to determine, as it may vary with age, weight, and concomitant conditions of the individual person.
Treatment to address an ibuprofen overdose is based on how the symptoms present. In cases presenting early, decontamination of the stomach is recommended. This is achieved using activated charcoal; charcoal adsorbs the drug before it can enter the bloodstream. Gastric lavage is now rarely used, but can be considered if the amount ingested is potentially life-threatening, and it can be performed within 60 minutes of ingestion. Purposeful vomiting is not recommended.[49] The majority of ibuprofen ingestions produce only mild effects, and the management of overdose is straightforward. Standard measures to maintain normal urine output should be instituted and kidney function monitored.[47] Since ibuprofen has acidic properties and is also excreted in the urine, forced alkaline diuresis is theoretically beneficial. However, because ibuprofen is highly protein-bound in the blood, the kidneys' excretion of unchanged drug is minimal. Forced alkaline diuresis is, therefore, of limited benefit.[50]

Miscarriage[edit]
A study of pregnant women suggests that those taking any type or amount of NSAIDs (including ibuprofen, diclofenac and naproxen) were 2.4 times more likely to miscarry than those not taking the medications.[51] However, an Israeli study found no increased risk of miscarriage in the group of mothers using NSAIDs.[52]

Pharmacology[edit]
NSAIDs such as ibuprofen work by inhibiting the cyclooxygenase (COX) enzymes, which convert arachidonic acid to prostaglandin H2 (PGH2). PGH2, in turn, is converted by other enzymes to several other prostaglandins (which are mediators of pain, inflammation, and fever) and to thromboxane A2 (which stimulates platelet aggregation, leading to the formation of blood clots).
Like aspirin and indomethacin, ibuprofen is a nonselective COX inhibitor, in that it inhibits two isoforms of cyclooxygenase, COX-1 and COX-2. The analgesic, antipyretic, and anti-inflammatory activity of NSAIDs appears to operate mainly through inhibition of COX-2, which decreases the synthesis of prostaglandins involved in mediating inflammation, pain, fever, and swelling. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. Inhibition of COX-1 instead would be responsible for unwanted effects on the gastrointestinal tract.[53] However, the role of the individual COX isoforms in the analgesic, anti-inflammatory, and gastric damage effects of NSAIDs is uncertain, and different compounds cause different degrees of analgesia and gastric damage.[54]
Ibuprofen is administered as a racemic mixture. The R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo. The S-enantiomer is believed to be the more pharmacologically active enantiomer.[55] The R-enantiomer is converted through a series of three main enzymes. These enzymes include acyl-CoA-synthetase, which converts the R-enantiomer to (−)-R-ibuprofen I-CoA; 2-arylpropionyl-CoA epimerase, which converts (−)-R-ibuprofen I-CoA to (+)-S-ibuprofen I-CoA; and hydrolase, which converts (+)-S-ibuprofen I-CoA to the S-enantiomer.[41] In addition to the conversion of ibuprofen to the S-enantiomer, the body can metabolize ibuprofen to several other compounds, including numerous hydroxyl, carboxyl and glucuronyl metabolites. Virtually all of these have no pharmacological effects.[41]
Unlike most other NSAIDs, ibuprofen also acts as an inhibitor of Rho kinase and may be useful in recovery from spinal-cord injury.[56][57]

Pharmacokinetics[edit]
After oral administration, peak serum concentration is reached after 1–2 hours, and up to 99% of the drug is bound to plasma proteins.[58] The majority of ibuprofen is metabolized and eliminated within 24 hours in the urine; however, 1% of the unchanged drug is removed through biliary excretion.[55]

Chemistry[edit]
Ibuprofen is practically insoluble in water, but very soluble in most organic solvents like ethanol (66.18 g/100 mL at 40 °C for 90% EtOH), methanol, acetone and dichloromethane.[59]
The original synthesis of ibuprofen by the Boots Group started with the compound 2-methylpropylbenzene. The synthesis took six steps. A modern, greener technique for the synthesis involves only three steps.[60]

Stereochemistry[edit]










(R)-ibuprofen
(S)-ibuprofen

Ibuprofen, like other 2-arylpropionate derivatives such as ketoprofen, flurbiprofen and naproxen, contains a stereocenter in the α-position of the propionate moiety. The product sold in pharmacies is a racemic mixture of the S and R-isomers. The S (dextrorotatory) isomer is the more biologically active; this isomer has been isolated and used medically (see dexibuprofen for details).[59]
The isomerase enzyme, alpha-methylacyl-CoA racemase, converts (R)-ibuprofen into the (S)-enantiomer.[61][62][63]


History[edit]
  The Royal Society of Chemistry blue plaque at BioCity Nottingham
Ibuprofen was derived from propionic acid by the research arm of Boots Group during the 1960s.[64] The name is derived from the 3 functional groups: isobutyl (ibu) propionic acid (pro) phenyl (fen). Its discovery was the result of research during the 1950s and 1960s to find a safer alternative to aspirin.[11][65] The molecule was discovered and synthesized by a team led by Stewart Adams, with a patent application filed in 1961.[11] Adams initially tested the drug as treatment for his hangover.[66]
Despite the fact that his name has been forgotten in history, for the development of the molecule, the role of catalan Antonio Ribera Blancafort was fundamental.[67]
[68]
The drug was launched as a treatment for rheumatoid arthritis in the United Kingdom in 1969, and in the United States in 1974. Later, in 1983 and 1984, it became the first NSAID (other than aspirin) to be available over the counter (OTC) in these two countries.[11][65] Dr. Adams was subsequently awarded an Order of the British Empire (OBE) in 1987. Boots was awarded the Queen's Award for Technical Achievement in 1987 for the development of the drug.[11]
In November 2013, work on ibuprofen was recognized by the erection of a Royal Society of Chemistry blue plaque at Boots' Beeston Factory site in Nottingham, which reads:[69][failed verification]

.mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0}In recognition of the work during the 1980s by The Boots Company PLC on the development of ibuprofen which resulted in its move from prescription only status to over the counter sale, therefore expanding its use to millions of people worldwide
and another at BioCity Nottingham, the site of the original laboratory, which reads:[69]

In recognition of the pioneering research work, here on Pennyfoot Street, by Dr Stewart Adams and Dr John Nicholson in the Research Department of Boots which led to the discovery of ibuprofen used by millions worldwide for the relief of pain.
Society and culture[edit]
Availability[edit]
See also: Ibuprofen brand names
  A bottle of generic ibuprofen
Ibuprofen was made available under prescription in the United Kingdom in 1969, and in the United States in 1974.[70] In the years since, the good tolerability profile, along with extensive experience in the population, as well as in so-called phase-IV trials (postapproval studies), have resulted in the availability of ibuprofen OTC in pharmacies worldwide, as well as in supermarkets and other general retailers.
Ibuprofen is its International nonproprietary name (INN), British Approved Name (BAN), Australian Approved Name (AAN) and United States Adopted Name (USAN). In the U.S., Motrin has been on the market since 1974,[71] and Advil has been on the market since 1984.[72] Ibuprofen is commonly available in the United States up to the FDA's 1984 dose limit OTC, rarely used higher by prescription.[73][failed verification]
In 2009, the first injectable formulation of ibuprofen was approved in the United States, under the trade name Caldolor.[74][75]

Route[edit]
It can be used by mouth, as a tablet, capsule or suspension, or intravenously.[7]

Research[edit]
Ibuprofen is sometimes used for the treatment of acne because of its anti-inflammatory properties, and has been sold in Japan in topical form for adult acne.[76][77] As with other NSAIDs, ibuprofen may be useful in the treatment of severe orthostatic hypotension (low blood pressure when standing up).[78] NSAIDs are of unclear utility in the prevention and treatment of Alzheimer's disease.[79][80]
Ibuprofen has been associated with a lower risk of Parkinson's disease and may delay or prevent it. Aspirin, other NSAIDs, and paracetamol (acetaminophen) had no effect on the risk for Parkinson's.[81] In March 2011, researchers at Harvard Medical School announced in Neurology that ibuprofen had a neuroprotective effect against the risk of developing Parkinson's disease.[82][83][84] People regularly consuming ibuprofen were reported to have a 38% lower risk of developing Parkinson's disease, but no such effect was found for other pain relievers, such as aspirin and paracetamol. Use of ibuprofen to lower the risk of Parkinson's disease in the general population would not be problem-free, given the possibility of adverse effects on the urinary and digestive systems.[85]
Some dietary supplements might be dangerous to take along with ibuprofen and other NSAIDs, but as of 2016[update] more research needs to be conducted to be certain. These supplements include those that can prevent platelet aggregation, including ginkgo, garlic, ginger, bilberry, dong quai, feverfew, ginseng, turmeric, meadowsweet (Filipendula ulmaria), and willow (Salix spp.); those that contain coumarin, including chamomile, horse chestnut, fenugreek and red clover; and those that increase the risk of bleeding, like tamarind.[86]

COVID‑19[edit]
Ibuprofen is being researched in Córdoba, Argentina as a treatment for COVID‑19, using it in a hypertonic solution and inhaling it. The clinical trials started in June 2020.[87] There is no validated (peer-reviewed) publication showing the effectiveness of ibuprofen in treatment of COVID‑19, nor is there any evidence that it blocks SARS-CoV-2 infectivity in any test, either on cultured cells or in animals. The only publication from the Argentine group is in the controversial journal "Medical Hypotheses"[88] and contains no data of any sort on the effectiveness of ibuprofen. It simply makes a hypothetical suggestion, based primarily on data from other viruses that are very different from SARS-CoV-2.


References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ Use During Pregnancy and Breastfeeding

^ .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}Davanzo R, Bua J, Paloni G, Facchina G (November 2014). "Breastfeeding and migraine drugs". European Journal of Clinical Pharmacology (Review). 70 (11): 1313–1324. doi:10.1007/s00228-014-1748-0. PMID 25217187. S2CID 17144030.

^ Jump up to: a b c Davies NM (February 1998). "Clinical pharmacokinetics of ibuprofen. The first 30 years". Clinical Pharmacokinetics. 34 (2): 101–154. doi:10.2165/00003088-199834020-00002. PMID 9515184. S2CID 1186212.

^ "ibuprofen". Archived from the original on 13 January 2015. Retrieved 31 January 2015.

^ Grosser T, Ricciotti E, FitzGerald GA (August 2017). "The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs". Trends in Pharmacological Sciences (Review). 38 (8): 733–748. doi:10.1016/j.tips.2017.05.008. PMC 5676556. PMID 28651847.

^ "Brufen Tablets And Syrup" (PDF). Therapeutic Goods Administration. 31 July 2012. Archived from the original on 20 August 2016. Retrieved 8 May 2014.

^ Jump up to: a b c d e f g h i j k l m "Ibuprofen". The American Society of Health-System Pharmacists. Archived from the original on 9 September 2017. Retrieved 12 October 2016.

^ Jump up to: a b c d British National Formulary, March 2014–September 2014 (2014 ed.). London: British Medical Association. 2014. pp. 686–688. ISBN 978-0857110862.

^ "Ibuprofen Pregnancy and Breastfeeding Warnings". Drugs.com. Archived from the original on 9 September 2017. Retrieved 22 May 2016.

^ Kindy D. "The Inventor of Ibuprofen Tested the Drug on His Own Hangover". Smithsonian Magazine. Retrieved 3 July 2021. Stewart Adams and his associate John Nicholson invented a pharmaceutical drug known as 2-(4-isobutylphenyl) propionic acid.

^ Jump up to: a b c d e f Halford GM, Lordkipanidzé M, Watson SP (2012). "50th anniversary of the discovery of ibuprofen: an interview with Dr Stewart Adams". Platelets. 23 (6): 415–422. doi:10.3109/09537104.2011.632032. PMID 22098129. S2CID 26344532.

^ "Chemistry in your cupboard: Nurofen". RSC Education. Archived from the original on 5 June 2014.

^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06.

^ "The Top 300 of 2019". ClinCalc. Retrieved 16 October 2021.

^ "Ibuprofen. Drug Usage Statistics". ClinCalc. Retrieved 16 October 2021.

^ "10.1.1 Non-steroidal anti-inflammatory drugs". British National Formulary. Archived from the original on 17 November 2016. Retrieved 13 April 2016.

^ Joint Formulary Committee (2013). British National Formulary (BNF) (65 ed.). London, UK: Pharmaceutical Press. pp. 665, 671. ISBN 978-0-85711-084-8.

^ Jump up to: a b c Rossi, S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3.

^ Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A (August 2014). "Colchicine for pericarditis" (PDF). The Cochrane Database of Systematic Reviews (Review). 8 (8): CD010652. doi:10.1002/14651858.CD010652.pub2. PMID 25164988.

^ Rostas SE, McPherson CC (2016). "Pharmacotherapy for Patent Ductus Arteriosus: Current Options and Outstanding Questions". Current Pediatric Reviews (Review). 12 (2): 110–9. doi:10.2174/157339631202160506002028. PMID 27197952.

^ "Ibuprofen for adults". NHS.{{cite web}}:  CS1 maint: url-status (link)

^ Beaver WT (April 2003). "Review of the analgesic efficacy of ibuprofen". International Journal of Clinical Practice. Supplement (135): 13–7. PMID 12723741.

^ Seibel K, Schaffler K, Reeh P, Reitmeir P (2004). "Comparison of two different preparations of ibuprofen with regard to the time course of their analgesic effect. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from UW-irritated skin in healthy volunteers". Arzneimittel-Forschung. 54 (8): 444–51. doi:10.1055/s-0031-1296997. PMID 15460211.

^ Kyselovič J, Koscova E, Lampert A, Weiser T (June 2020). "A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Lysinate in Comparison to Ibuprofen Acid for Acute Postoperative Dental Pain". Pain and Therapy. 9 (1): 249–259. doi:10.1007/s40122-019-00148-1. PMC 7203382. PMID 31912434.

^ Fanos V, Antonucci R, Zaffanello M (2010). "Ibuprofen and acute kidney injury in the newborn". The Turkish Journal of Pediatrics. 52 (3): 231–8. PMID 20718179.

^ Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F,  et al. (December 2012). "Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)". Drug Safety. 35 (12): 1127–46. doi:10.1007/BF03261999. PMC 3714137. PMID 23137151.

^ Ayres JG, Fleming DM, Whittington RM (May 1987). "Asthma death due to ibuprofen". Lancet. 1 (8541): 1082. doi:10.1016/S0140-6736(87)90499-5. PMID 2883408. S2CID 38589434.

^ Shaikhain TA, Al-Husayni F, Elder K (December 2019). "Ibuprofen-induced Anaphylactic Shock in Adult Saudi Patient". Cureus. 11 (12): e6425. doi:10.7759/cureus.6425. PMC 6970456. PMID 31993263.

^ Baselt R (2008). Disposition of Toxic Drugs and Chemicals in Man (8th ed.). Foster City, USA: Biomedical Publications. pp. 758–761.

^ Jump up to: a b "FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications". U.S. Food and Drug Administration (FDA) (Press release). 15 October 2020. Retrieved 15 October 2020.  This article incorporates text from this source, which is in the public domain.

^ Jump up to: a b "NSAIDs may cause rare kidney problems in unborn babies". U.S. Food and Drug Administration. 21 July 2017. Retrieved 15 October 2020.  This article incorporates text from this source, which is in the public domain.

^ Forman JP, Stampfer MJ, Curhan GC (September 2005). "Non-narcotic analgesic dose and risk of incident hypertension in US women". Hypertension. 46 (3): 500–7. doi:10.1161/01.HYP.0000177437.07240.70. PMID 16103274.

^ Hippisley-Cox J, Coupland C (June 2005). "Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis". BMJ. 330 (7504): 1366. doi:10.1136/bmj.330.7504.1366. PMC 558288. PMID 15947398.

^ "FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes". U.S. Food and Drug Administration (FDA). 9 July 2015. Archived from the original on 28 October 2019. Retrieved 9 July 2015. Lay summary. {{cite web}}: Cite uses deprecated parameter |lay-url= (help)

^ "Ibuprofen- and dexibuprofen-containing medicines". European Medicines Agency (EMA). 22 May 2015. EMA/325007/2015. Archived from the original on 28 October 2019. Retrieved 28 October 2019.

^ "High-dose ibuprofen (≥2400mg/day): small increase in cardiovascular risk". Medicines and Healthcare products Regulatory Agency (MHRA). 26 June 2015. Archived from the original on 28 October 2019. Retrieved 28 October 2019.

^ Chan LS (12 June 2014).  Hall, R, Vinson, RP, Nunley, JR, Gelfand, JM, Elston, DM (eds.). "Bullous Pemphigoid Clinical Presentation". Medscape Reference. United States: WebMD. Archived from the original on 10 November 2011.

^ Bergner T, Przybilla B (January 1992). "Photosensitization caused by ibuprofen". Journal of the American Academy of Dermatology. 26 (1): 114–6. doi:10.1016/0190-9622(92)70018-b. PMID 1531054.

^ Raksha MP, Marfatia YS (2008). "Clinical study of cutaneous drug eruptions in 200 patients". Indian Journal of Dermatology, Venereology and Leprology. 74 (1): 80. doi:10.4103/0378-6323.38431. PMID 18193504.

^ Ward KE, Archambault R, Mersfelder TL (February 2010). "Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature". American Journal of Health-System Pharmacy. 67 (3): 206–13. doi:10.2146/ajhp080603. PMID 20101062.

^ Jump up to: a b c Rainsford KD (2012). Ibuprofen: Pharmacology, Therapeutics and Side Effects. London: Springer.

^ "Ibuprofen". Drugs.com. Archived from the original on 6 August 2011.

^ "Information for Healthcare Professionals: Concomitant Use of Ibuprofen and Aspirin". U.S. Food and Drug Administration (FDA). September 2006. Archived from the original on 13 November 2010. Retrieved 22 November 2010. Lay summary. {{cite web}}: Cite uses deprecated parameter |lay-url= (help)

^ Kanabar DJ (February 2017). "A clinical and safety review of paracetamol and ibuprofen in children". Inflammopharmacology. 25 (1): 1–9. doi:10.1007/s10787-016-0302-3. PMC 5306275. PMID 28063133.

^ McElwee NE, Veltri JC, Bradford DC, Rollins DE (June 1990). "A prospective, population-based study of acute ibuprofen overdose: complications are rare and routine serum levels not warranted". Annals of Emergency Medicine. 19 (6): 657–662. doi:10.1016/S0196-0644(05)82471-0. PMID 2188537.

^ Vale JA, Meredith TJ (January 1986). "Acute poisoning due to non-steroidal anti-inflammatory drugs. Clinical features and management". Medical Toxicology. 1 (1): 12–31. doi:10.1007/BF03259825. PMID 3537613. S2CID 25223555.

^ Jump up to: a b Volans G, Hartley V, McCrea S, Monaghan J (March–April 2003). "Non-opioid analgesic poisoning". Clinical Medicine. 3 (2): 119–123. doi:10.7861/clinmedicine.3-2-119. PMC 4952728. PMID 12737366.

^ Seifert SA, Bronstein AC, McGuire T (2000). "Massive ibuprofen ingestion with survival". Journal of Toxicology. Clinical Toxicology. 38 (1): 55–57. doi:10.1081/clt-100100917. PMID 10696926. S2CID 38588541.

^ American Academy Of Clinical Toxico (2004). "Position paper: Ipecac syrup". Journal of Toxicology. Clinical Toxicology. 42 (2): 133–143. doi:10.1081/CLT-120037421. PMID 15214617.

^ Hall AH, Smolinske SC, Conrad FL, Wruk KM, Kulig KW, Dwelle TL, Rumack BH (November 1986). "Ibuprofen overdose: 126 cases". Annals of Emergency Medicine. 15 (11): 1308–1313. doi:10.1016/S0196-0644(86)80617-5. PMID 3777588.

^ Verma P, Clark CA, Spitzer KA, Laskin CA, Ray J, Koren G (July 2012). "Use of non-aspirin NSAIDs during pregnancy may increase the risk of spontaneous abortion". Evidence-Based Nursing. 15 (3): 76–77. doi:10.1136/ebnurs-2011-100439. PMID 22411163. S2CID 28521248.

^ Daniel S, Koren G, Lunenfeld E, Bilenko N, Ratzon R, Levy A (March 2014). "Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions". CMAJ. 186 (5): E177–E182. doi:10.1503/cmaj.130605. PMC 3956584. PMID 24491470.

^ Rao P, Knaus EE (September 2008). "Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond". Journal of Pharmacy & Pharmaceutical Sciences. 11 (2): 81s–110s. doi:10.18433/J3T886. PMID 19203472.

^ Kakuta H, Zheng X, Oda H, Harada S, Sugimoto Y, Sasaki K, Tai A (April 2008). "Cyclooxygenase-1-selective inhibitors are attractive candidates for analgesics that do not cause gastric damage. design and in vitro/in vivo evaluation of a benzamide-type cyclooxygenase-1 selective inhibitor". Journal of Medicinal Chemistry. 51 (8): 2400–2411. doi:10.1021/jm701191z. PMID 18363350.

^ Jump up to: a b "Ibuprofen". DrugBank. Archived from the original on 21 July 2014. Retrieved 24 July 2014.

^ Kopp MA, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing GJ,  et al. (July 2012). "Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury". Cell and Tissue Research. 349 (1): 119–132. doi:10.1007/s00441-012-1334-7. PMC 3744771. PMID 22350947.

^ Luo M, Li YQ, Lu YF, Wu Y, Liu R, Zheng YR, Yin M (November 2020). "Exploring the potential of RhoA inhibitors to improve exercise-recoverable spinal cord injury: A systematic review and meta-analysis". Journal of Chemical Neuroanatomy. 111: 101879. doi:10.1016/j.jchemneu.2020.101879. PMID 33197553.

^ Bushra R, Aslam N (July 2010). "An overview of clinical pharmacology of Ibuprofen". Oman Medical Journal. 25 (3): 155–161. doi:10.5001/omj.2010.49. PMC 3191627. PMID 22043330.

^ Jump up to: a b Brayfield, A, ed. (14 January 2014). "Ibuprofen". Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. Retrieved 26 June 2014.

^ "The Synthesis of Ibuprofen". Royal Society of Chemistry. Retrieved 22 November 2018.

^ Tracy TS, Hall SD (March–April 1992). "Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A". Drug Metabolism and Disposition. 20 (2): 322–327. PMID 1352228.

^ Chen CS, Shieh WR, Lu PH, Harriman S, Chen CY (July 1991). "Metabolic stereoisomeric inversion of ibuprofen in mammals". Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1078 (3): 411–417. doi:10.1016/0167-4838(91)90164-U. PMID 1859831.

^ Reichel C, Brugger R, Bang H, Geisslinger G, Brune K (April 1997). "Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen" (PDF). Molecular Pharmacology. 51 (4): 576–582. doi:10.1124/mol.51.4.576. PMID 9106621. S2CID 835701. Archived from the original (PDF) on 2 March 2019.

^ Adams SS (April 1992). "The propionic acids: a personal perspective". Journal of Clinical Pharmacology. 32 (4): 317–323. doi:10.1002/j.1552-4604.1992.tb03842.x. PMID 1569234. S2CID 22857259.

^ Jump up to: a b Rainsford KD (April 2003). "Discovery, mechanisms of action and safety of ibuprofen". International Journal of Clinical Practice. Supplement (135): 3–8. PMID 12723739.

^ Lambert V (8 October 2007). "Dr Stewart Adams: 'I tested ibuprofen on my hangover'". The Daily Telegraph. UK. Archived from the original on 18 November 2015. Retrieved 23 October 2015.(Subscription required.)

^ Abel G.M. "Antonio Ribera Blancafort, el padre del ibuprofeno". historia.nationalgeographic.com.es/. Retrieved 26 December 2021.

^ "El 'Padre' Español del Ibuprofeno, Por Qué Reino Unido Ignora al Dr. Ribera". elespanol.com. Retrieved 26 December 2021.

^ Jump up to: a b "Chemical landmark plaque honours scientific discovery past and future" (Press release). Royal Society of Chemistry (RSC). 21 November 2013.

^ "Written submission to the NDAC meeting on risks of NSAIDs presented by the International Ibuprofen Foundation". U.S. Food and Drug Administration (FDA). August 2002. Archived from the original on 15 August 2013. Retrieved 20 March 2014.

^ "New Drug Application (NDA): 017463". U.S. Food and Drug Administration (FDA). Archived from the original on 28 October 2019. Retrieved 28 October 2019.

^ "New Drug Application (NDA): 018989". U.S. Food and Drug Administration (FDA). Archived from the original on 28 October 2019. Retrieved 28 October 2019.

^ "Ibuprofen". U.S. Food and Drug Administration (FDA). Archived from the original on 16 September 2011.{{cite web}}:  CS1 maint: unfit URL (link)

^ "Drug Approval Package: Caldolor (Ibuprofen) NDA #022348". U.S. Food and Drug Administration (FDA). 11 March 2010. Archived from the original on 19 October 2012.

^ "FDA Approves Injectable Form of Ibuprofen" (Press release). U.S. Food and Drug Administration (FDA). 11 June 2009. Archived from the original on 18 October 2012.

^ Wong RC, Kang S, Heezen JL, Voorhees JJ, Ellis CN (December 1984). "Oral ibuprofen and tetracycline for the treatment of acne vulgaris". Journal of the American Academy of Dermatology. 11 (6): 1076–1081. doi:10.1016/S0190-9622(84)80192-9. PMID 6239884.

^ "In Japan, an OTC ibuprofen ointment (Fukidia) for alleviating adult acne has been launched". Inpharma. 1 (1530): 18. 25 March 2006. doi:10.2165/00128413-200615300-00043. ISSN 1173-8324. S2CID 195105870.

^ Zawada ET (May 1982). "Renal consequences of nonsteroidal antiinflammatory drugs". Postgraduate Medicine. 71 (5): 223–230. doi:10.1080/00325481.1982.11716077. PMID 7041104.

^ Miguel-Álvarez M, Santos-Lozano A, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, Lucia A (February 2015). "Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect". Drugs & Aging. 32 (2): 139–147. doi:10.1007/s40266-015-0239-z. PMID 25644018. S2CID 35357112.

^ Wang J, Tan L, Wang HF, Tan CC, Meng XF, Wang C,  et al. (2015). "Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis". Journal of Alzheimer's Disease. 44 (2): 385–396. doi:10.3233/JAD-141506. PMID 25227314.

^ Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A (December 2005). "Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease". Annals of Neurology. 58 (6): 963–967. doi:10.1002/ana.20682. PMID 16240369. S2CID 30843070.

^ Bower JH, Ritz B (March 2011). "Is the answer for Parkinson disease already in the medicine cabinet?: Unfortunately not". Neurology. 76 (10): 854–855. doi:10.1212/WNL.0b013e31820f2e7a. PMID 21368280. S2CID 46104705.

^ Gao X, Chen H, Schwarzschild MA, Ascherio A (March 2011). "Use of ibuprofen and risk of Parkinson disease". Neurology. 76 (10): 863–9. doi:10.1212/WNL.0b013e31820f2d79. PMC 3059148. PMID 21368281.

^ McSharry C (May 2011). "Parkinson disease: Could over-the-counter treatment protect against Parkinson disease?". Nature Reviews. Neurology. 7 (5): 244. doi:10.1038/nrneurol.2011.49. PMID 21555992. S2CID 35880887.

^ Gleason JM, Slezak JM, Jung H, Reynolds K, Van den Eeden SK, Haque R,  et al. (April 2011). "Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction". The Journal of Urology. 185 (4): 1388–1393. doi:10.1016/j.juro.2010.11.092. PMID 21334642.

^ Abebe W (December 2002). "Herbal medication: potential for adverse interactions with analgesic drugs". Journal of Clinical Pharmacy and Therapeutics. 27 (6): 391–401. doi:10.1046/j.1365-2710.2002.00444.x. PMID 12472978. S2CID 1828900.

^ "Coronavirus en Argentina: cómo es el tratamiento con ibuprofeno que también están probando en Jujuy". Clarín (in Spanish). 2020.

^ García, Néstor H.; Porta, Daniela J.; Alasino, Roxana V.; Muñoz, Sonia E.; Beltramo, Dante M. (2020). "Ibuprofen, a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution". Medical Hypotheses. 144: 110079. doi:10.1016/j.mehy.2020.110079. PMC 7340056. PMID 32758897.


External links[edit]



Wikimedia Commons has media related to Ibuprofen.

"Ibuprofen". Drug Information Portal. U.S. National Library of Medicine.
.mw-parser-output .citation{word-wrap:break-word}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}GB patent 971700, Stewart Sanders Adams & John Stuart Nicholson, "Anti-Inflammatory Agents", published 1964-09-30,  assigned to BOOTS PURE DRUG CO LTD 
"Evidence for the efficacy of pain medications" (PDF). National Safety Council (NSC). 26 August 2020.
.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vteNonsteroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)Pyrazolones / Pyrazolidines
Aminophenazone
Ampyrone
Azapropazone
Clofezone
Difenamizole
Famprofazone
Feprazone
Kebuzone
Metamizole
Mofebutazone
Morazone
Nifenazone
Oxyphenbutazone
Phenazone
Phenylbutazone
Propyphenazone
Sulfinpyrazone
Suxibuzone‡
Salicylates
Aspirin (acetylsalicylic acid)#
Aloxiprin
Benorylate
Carbasalate calcium
Diflunisal
Dipyrocetyl
Ethenzamide
Guacetisal
Magnesium salicylate
Methyl salicylate
Salsalate
Salicin
Salicylamide
Salicylic acid (salicylate)
Sodium salicylate
Acetic acid derivativesand related substances
Aceclofenac
Acemetacin
Alclofenac
Amfenac
Bendazac
Bromfenac
Bumadizone
Bufexamac
Diclofenac
Difenpiramide
Etodolac
Felbinac
Fenclozic acid
Fentiazac
Indometacin
Indometacin farnesil
Isoxepac
Ketorolac
Lonazolac
Mofezolac
Oxametacin
Prodolic acid
Proglumetacin
Sulindac
Tiopinac
Tolmetin
Zomepirac†
Oxicams
Ampiroxicam
Droxicam
Isoxicam
Lornoxicam
Meloxicam
Piroxicam
Tenoxicam
Propionic acid derivatives(profens)
Alminoprofen
Benoxaprofen†
Carprofen‡
Dexibuprofen
Dexketoprofen
Fenbufen
Fenoprofen
Flunoxaprofen
Flurbiprofen
Ibuprofen#
Ibuproxam
Indoprofen†
Ketoprofen
Loxoprofen
Miroprofen
Naproxen
Oxaprozin
Piketoprofen
Pirprofen
Suprofen
Tarenflurbil
Tepoxalin‡
Tiaprofenic acid
Vedaprofen‡
Zaltoprofen
COX-inhibiting nitric oxide donator: Naproxcinod
N-Arylanthranilic acids(fenamates)
Azapropazone
Clonixin
Etofenamate
Floctafenine
Flufenamic acid
Flunixin
Glafenine†
Meclofenamic acid
Mefenamic acid
Morniflumate
Niflumic acid
Tolfenamic acid
Flutiazin
Coxibs
Apricoxib
Celecoxib (+tramadol)
Cimicoxib‡
Deracoxib‡
Etoricoxib
Firocoxib‡
Lumiracoxib†
Mavacoxib‡
Parecoxib
Robenacoxib‡
Rofecoxib†
Valdecoxib†
Other
Aminopropionitrile
Benzydamine
Chondroitin sulfate
Diacerein
Fluproquazone
Glucosamine
Glycosaminoglycan
Hyperforin
Nabumetone
Nimesulide
Oxaceprol
Proquazone
Superoxide dismutase/Orgotein
Tenidap
Combinations
Ibuprofen/famotidine
Ibuprofen/hydrocodone
Ibuprofen/oxycodone
Ibuprofen/paracetamol
Meloxicam/bupivacaine
Naproxen/diphenhydramine
Naproxen/esomeprazole
Items listed in underline indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications.
vteTopical products for joint and muscular pain (M02)Anti-inflammatory preparations, non-steroidsPyrazolidines
Clofezone
Mofebutazone
Oxyphenbutazone
Phenylbutazone
Acetic acid derivatives
Diclofenac
Fentiazac
Tolmetin
Other
Bendazac
Benzydamine
Bufexamac
Etofenamate
Felbinac
Feprazone
Flurbiprofen
Ibuprofen
Indometacin
Ketoprofen
Meclofenamic acid
Naproxen
Nifenazone
Niflumic acid
Piketoprofen
Piroxicam
Suxibuzone
Capsaicin derivatives
Zucapsaicin
Other
Dimethyl sulfoxide
Idrocilamide
Tolazoline

vteAnalgesics (N02A, N02B)OpioidsOpiates/opium
Codeine#
+aspirin
+paracetamol
Morphine# (+naltrexone)
Opium
Laudanum
Paregoric
Semisynthetic
Acetyldihydrocodeine
Benzylmorphine
Buprenorphine (+naloxone)
Butorphanol
Desomorphine
Diamorphine (heroin)
Dihydrocodeine (+paracetamol)
Dihydromorphine
Etorphine
Ethylmorphine
Hydrocodone (+paracetamol, +ibuprofen, +aspirin)
Hydromorphinol
Hydromorphone
Levorphanol
Metopon
Nalbuphine
Nicocodeine
Nicodicodine
Nicomorphine
Oxycodone (+paracetamol, +aspirin, +ibuprofen, +naloxone, +naltrexone)
Oxymorphone
Papaveretum
Thebacon
Synthetic
Alfentanil
Alphaprodine
Anileridine
Bezitramide
Carfentanil
Dextromoramide
Dextropropoxyphene
Dezocine
Dimenoxadol
Dipipanone
Ethoheptazine
Fentanyl# (+fluanisone)
Ketobemidone
Lofentanil
Meptazinol
Methadone#
NFEPP
Norpipanone
Oliceridine
Pentazocine
Pethidine (meperidine)
Phenadoxone
Phenazocine
Phenoperidine
Piminodine
Piritramide
Proheptazine
Propiram
Remifentanil
Sufentanil
Tapentadol
Tilidine
Tramadol
Viminol
Paracetamol-type
Acetanilide‡
Bucetin‡
Butacetin‡
Paracetamol (acetaminophen)#
+aspirin/caffeine
+codeine
+hydrocodone
+metoclopramide
+oxycodone
+propyphenazone/caffeine
Parapropamol‡
Phenacetin‡
Propacetamol‡
NSAIDsPropionates
Benoxaprofen ‡
Fenoprofen
Flurbiprofen
Ibuprofen# (Dexibuprofen)
Ketoprofen (Dexketoprofen)
Loxoprofen
Naproxen
Oxaprozin
Suprofen
Tiaprofenic acid
Zaltoprofen
Oxicams
Isoxicam
Lornoxicam
Meloxicam
Piroxicam
Tenoxicam
Acetates
Acemetacin
Bromfenac
Diclofenac
Etodolac
Indometacin (Indometacin farnesil)
Ketorolac
Sulindac
Tolmetin
Zomepirac ‡
COX-2 inhibitors
Celecoxib (+tramadol)
Etoricoxib
Lumiracoxib ‡
Parecoxib
Rofecoxib ‡
Valdecoxib ‡
Fenamates
Flufenamic acid
Meclofenamic acid
Mefenamic acid
Tolfenamic acid
Salicylates
Aspirin (acetylsalicylic acid)# (+paracetamol/caffeine)
Aloxiprin
Benorylate
Carbasalate calcium
Choline salicylate
Diflunisal
Dipyrocetyl
Ethenzamide
Guacetisal
Imidazole salicylate
Magnesium salicylate
Morpholine salicylate
Potassium salicylate
Salicin
Salicylamide
Salsalate
Sodium salicylate
Wintergreen (methyl salicylate)
Pyrazolones
Aminophenazone‡
Ampyrone
Metamizole (dipyrone)
Nifenazone
Phenazone
Propyphenazone (+paracetamol/caffeine)
Others
Benzydamine
Floctafenine
Glafenine
Nabumetone
Nimesulide
Proquazone
Cannabinoids
Cannabidiol
Cannabis
Nabilone
Nabiximols
Tetrahydrocannabinol (dronabinol)
Ion channelmodulatorsCalcium blockers
Alcohol (ethanol)
Gabapentin
Gabapentin enacarbil
Leconotide
Mirogabalin
Pregabalin
Ziconotide
Sodium blockers
Carbamazepine
Lacosamide
Local anesthetics (e.g., cocaine, lidocaine)
Mexiletine
Nefopam
Tricyclic antidepressants (e.g., amitriptyline#)
Nav1.7/1.8-selective: DSP-2230§
Funapide§
PF-05089771§
Potassium openers
Flupirtine‡
Myorelaxants
Carisoprodol
Chlorzoxazone
Cyclobenzaprine
Mephenoxalone
Methocarbamol
Orphenadrine
Others
Analgecine
Analgesic adjuvant
Bedinvetmab
Camphor
Capsaicin
Clonidine
Frunevetmab
Ketamine
Menthol
Methoxyflurane
Phenazopyridine
Proglumide
Rimazolium
Tanezumab

#WHO-EM
‡Withdrawn from market
Clinical trials:
†Phase III
§Never to phase III

vteAcne-treating agents (D10)Antibacterial
Azelaic acid
Benzoyl peroxide#
8-Hydroxyquinoline
Blue light therapy
Tea tree oil
Keratolytic
Glycolic acid
Salicylic acid#
Sulfur
Benzoyl peroxide#
Anti-inflammatory
Niacinamide
Ibuprofen#
Aspirin#
Red light therapy
Antibiotics
Clindamycin
Dapsone
Erythromycin
Sulfacetamide
Tetracyclines (Lymecycline
Minocycline
Doxycycline)
Hormonal
Antiandrogens
Bicalutamide
Cyproterone acetate
Drospirenone
Flutamide
Spironolactone)
Estrogens
Estradiol
Ethinylestradiol
Retinoids
Adapalene
Isotretinoin
Motretinide
Tazarotene
Tretinoin
Trifarotene
Other
Benzamycin
Epristeride
Mesulfen
Pelretin
Stridex
Tioxolone
Combinations
Adapalene/benzoyl peroxide
Benzoyl peroxide/clindamycin
Clindamycin/tretinoin
Erythromycin/isotretinoin
Sulfacetamide/sulfur
Tretinoin/benzoyl peroxide

#WHO-EM
‡Withdrawn from market
Clinical trials:
†Phase III
§Never to phase III

vteProlactin inhibitors and anti-inflammatory products for vaginal administration (G02CB–G02CC)Prolactin inhibitors
Bromocriptine
Cabergoline
Ergoloid
Lisuride
Metergoline
Pergolide
Quinagolide
Terguride
Anti-inflammatory productsfor vaginal administration
Benzydamine
Ibuprofen
Flunoxaprofen
Naproxen

vteProstanoid signaling modulatorsReceptor(ligands)DP (D2)DP1
Agonists: Prostaglandin D2
Treprostinil
Antagonists: Asapiprant
Laropiprant
Vidupiprant
DP2
Agonists: Indometacin
Prostaglandin D2
Antagonists: ADC-3680
AZD-1981
Bay U3405
Fevipiprant
MK-1029
MK-7246
QAV-680
Ramatroban
Setipiprant
Timapiprant
TM30089
Vidupiprant
EP (E2)EP1
Agonists: Beraprost
Enprostil
Iloprost (ciloprost)
Latanoprost
Lubiprostone
Misoprostol
Prostaglandin E1 (alprostadil)
Prostaglandin E2 (dinoprostone)
Sulprostone
Antagonists: AH-6809
ONO-8130
SC-19220
SC-51089
SC-51322
EP2
Agonists: Butaprost
Misoprostol
Prostaglandin E1 (alprostadil)
Prostaglandin E2 (dinoprostone)
Treprostinil
Antagonists: AH-6809
PF-04418948
TG 4-155
EP3
Agonists: Beraprost
Carbacyclin
Cicaprost
Enprostil
Iloprost (ciloprost)
Isocarbacyclin
Latanoprost
Misoprostol
Prostaglandin D2
Prostaglandin E1 (alprostadil)
Prostaglandin E2 (dinoprostone)
Remiprostol
Ricinoleic acid
Sulprostone
Antagonists: L-798106
EP4
Agonists: Lubiprostone
Misoprostol
Prostaglandin E1 (alprostadil)
Prostaglandin E2 (dinoprostone)
TCS-2510
Antagonists: Grapiprant
GW-627368
L-161982
ONO-AE3-208
Unsorted
Agonists: 16,16-Dimethyl Prostaglandin E2
Aganepag
Carboprost
Evatanepag
Gemeprost
Nocloprost
Omidenepag
Prostaglandin F2α (dinoprost)
Simenepag
Taprenepag
FP (F2α)
Agonists: Alfaprostol
Bimatoprost
Carboprost
Cloprostenol
Enprostil
Fluprostenol
Latanoprost
Prostaglandin D2
Prostaglandin F2α (dinoprost)
Sulotroban
Tafluprost
Travoprost
Unoprostone
IP (I2)
Agonists: ACT-333679
AFP-07
Beraprost
BMY-45778
Carbacyclin
Cicaprost
Iloprost (ciloprost)
Isocarbacyclin
MRE-269
NS-304
Prostacyclin (prostaglandin I2, epoprostenol)
Prostaglandin E1 (alprostadil)
Ralinepag
Selexipag
Taprostene
TRA-418
Treprostinil
Antagonists: RO1138452
TP (TXA2)
Agonists: Carbocyclic thromboxane A2
I-BOP
Thromboxane A2
U-46619
Vapiprost
Antagonists: 12-HETE
13-APA
AA-2414
Argatroban
Bay U3405
BMS-180,291
Daltroban
Domitroban
EP-045
GR-32191
ICI-185282
ICI-192605
Ifetroban
Imitrodast
L-655240
L-670596
Linotroban
Mipitroban
ONO-3708
ONO-11120
Picotamide
Pinane thromboxane A2
Ramatroban
Ridogrel
S-145
Samixogrel
Seratrodast
SQ-28,668
SQ-29,548
Sulotroban
Terbogrel
Terutroban
TRA-418
Unsorted
Arbaprostil
Ataprost
Ciprostene
Clinprost
Cobiprostone
Delprostenate
Deprostil
Dimoxaprost
Doxaprost
Ecraprost
Eganoprost
Enisoprost
Eptaloprost
Esuberaprost
Etiproston
Fenprostalene
Flunoprost
Froxiprost
Lanproston
Limaprost
Luprostiol
Meteneprost
Mexiprostil
Naxaprostene
Nileprost
Nocloprost
Ornoprostil
Oxoprostol
Penprostene
Pimilprost
Piriprost
Posaraprost
Prostalene
Rioprostil
Rivenprost
Rosaprostol
Spiriprostil
Tiaprost
Tilsuprost
Tiprostanide
Trimoprostil
Viprostol
Enzyme(inhibitors)COX(PTGS)
Salicylic acids: Aloxiprin
Aspirin (acetylsalicylic acid)
Benorilate (benorylate)
Carbasalate calcium
Diflusinal
Dipyrocetyl
Ethenzamide
Guacetisal
Magnesium salicylate
Mesalazine (5-aminosalicylic acid)
Methyl salicylate
Salacetamide
Salicin
Salicylamide
Salicylate (salicylic acid)
Salsalate
Sodium salicylate
Triflusal; Acetic acids: Aceclofenac
Acemetacin
Aclofenac
Amfenac
Alclofenac
Bendazac
Bromfenac
Bufexamac
Bumadizone
Cinmetacin
Clometacin
Diclofenac
Difenpiramide
Etodolac
Felbinac
Fenclofenac
Fentiazac
Glucametacin
Indometacin (indomethacin)
Indometacin farnesil
Ketorolac
Lonazolac
Mofezolac
Nabumetone
Oxametacin
Oxindanac
Proglumetacin
Sulindac
Sulindac sulfide
Tolmetin
Zidometacin
Zomepirac; Propionic acids: Alminoprofen
Benoxaprofen
Bucloxic acid (blucloxate)
Butibufen
Carprofen
Dexibuprofen
Dexindoprofen
Dexketoprofen
Fenbufen
Fenoprofen
Flunoxaprofen
Flurbiprofen
Ibuprofen
Ibuproxam
Indoprofen
Ketoprofen
Loxoprofen
Miroprofen
Naproxen
Naproxcinod
Oxaprozin
Pirprofen
Pranoprofen
Suprofen
Tarenflurbil
Tepoxalin
Tiaprofenic acid (tiaprofenate)
Vedaprofen; Anthranilic acids (fenamic acids): Etofenamic acid (etofenamate)
Floctafenic acid (floctafenate)
Flufenamic acid (flufenamate)
Meclofenamic acid (meclofenamate)
Mefenamic acid (mefenamate)
Morniflumic acid (morniflumate)
Niflumic acid (niflumate)
Talinflumic acid (talinflumate)
Tolfenamic acid (tolfenamate); Pyrazolones: Azapropazone
Dipyrone
Isopyrin
Oxyphenbutazone
Phenylbutazone; Enolic acids (oxicams): Ampiroxicam
Droxicam
Enolicam
Isoxicam
Lornoxicam
Meloxicam
Piroxicam
Tenoxicam; 4-Aminoquinolines: Antrafenine
Floctafenine
Glafenine; Quinazolines: Fluproquazone
Proquazone; Aminonicotinic acids: Clonixeril
Clonixin
Flunixin; Sulfonanilides: Flosulide
Nimesulide; Aminophenols (anilines): Acetanilide
AM-404 (N-arachidonoylaminophenol)
Bucetin
Paracetamol (acetaminophen)
Parapropamol
Phenacetin
Propacetamol; Selective COX-2 inhibitors (coxibs): Apricoxib
Celecoxib
Cimicoxib
Deracoxib
Etoricoxib
Firocoxib
Lumiracoxib
Mavacoxib
Parecoxib
Polmacoxib
Robenacoxib
Rofecoxib
Tilmacoxib
Valdecoxib; Others/unsorted: Anitrazafen
Clobuzarit
Curcumin
DuP-697
FK-3311
Flumizole
FR-122047
Glimepiride
Hyperforin
Itazigrel
L-655240
L-670596
Licofelone
Menatetrenone (vitamin K2)
NCX-466
NCX-4040
NS-398
Pamicogrel
Resveratrol
Romazarit
Rosmarinic acid
Rutecarpine
Satigrel
SC-236
SC-560
SC-58125
Tenidap
Tiflamizole
Timegadine
Trifenagrel
Tropesin
PGD2S
Retinoids
Selenium (selenium tetrachloride, sodium selenite, selenium disulfide)
PGESHQL-79PGFSBimatoprostPGI2STranylcypromineTXAS
Camonagrel
Dazmegrel
Dazoxiben
Furegrelate
Isbogrel
Midazogrel
Nafagrel
Nicogrelate
Ozagrel
Picotamide
Pirmagrel
Ridogrel
Rolafagrel
Samixogrel
Terbogrel
U63557A
Others
Precursors: Linoleic acid
γ-Linolenic acid (gamolenic acid)
Dihomo-γ-linolenic acid
Diacylglycerol
Arachidonic acid
Prostaglandin G2
Prostaglandin H2

See also
Receptor/signaling modulators
Leukotriene signaling modulators

vtePPAR modulatorsPPARα
Agonists: 15-HETE
15-HpETE
Aleglitazar
Aluminium clofibrate
Arachidonic acid
Bezafibrate
Clofibrate
CP-775146
Daidzein
DHEA (prasterone) (in rodents)
Elafibranor
Etomoxir
Fenofibrate
Genistein
Gemfibrozil
GW-7647
Lanifibranor
Leukotriene B4
LG-101506
LG-100754
Lobeglitazone
Muraglitazar
Oleylethanolamide
Palmitoylethanolamide
Pemafibrate
Perfluorononanoic acid
Perfluorooctanoic acid
Pioglitazone
Saroglitazar
Sodelglitazar
Tesaglitazar
Tetradecylthioacetic acid
Troglitazone
WY-14643
Antagonists: GW-6471
MK-886
PPARδ
Agonists: 15-HETE
15-HpETE
Arachidonic acid
Bezafibrate
Daidzein
Elafibranor
Fonadelpar
Genistein
GW-0742
GW-501516
L-165,041
Lanifibranor
LG-101506
Seladelpar
Sodelglitazar
Tetradecylthioacetic acid
Antagonists: FH-535
GSK-0660
GSK-3787
PPARγ
Agonists: 5-Oxo-ETE
5-Oxo-15-hydroxy-ETE
15-Deoxy-Δ12,14-prostaglandin J2
15-HETE
15-HpETE
Aleglitazar
Arachidonic acid
Balaglitazone
Berberine
Bezafibrate
Cannabidiol
Cevoglitazar
Ciglitazone
Daidzein
Darglitazone
Edaglitazone
Efatutazone
Englitazone
Etalocib
Farglitazar
Genistein
GW-1929
Ibuprofen
Imiglitazar
Indeglitazar
Lanifibranor
LG-100268
LG-100754
LG-101506
Lobeglitazone
Muraglitazar (muroglitazar)
nTZDpa
Naveglitazar
Netoglitazone
Oxeglitazar
Peliglitazar
Pemaglitazar
Perfluorononanoic acid
Pioglitazone
Prostaglandin J2
Ragaglitazar
Reglitazar
Rivoglitazone
Rosiglitazone
RS5444
Saroglitazar
Sipoglitazar
Sodelglitazar
Telmisartan
Tesaglitazar
Troglitazone
SPPARMs: BADGE
EPI-001
INT-131
MK-0533
S26948
Antagonists: FH-535
GW-9662
SR-202
T-0070907
Unknown: SR-1664
Non-selective
Agonists: Ciprofibrate
Clinofibrate
Clofibride
Englitazone
Etofibrate
Farglitazar
Netoglitazone
Ronifibrate
Rivoglitazone
Simfibrate

See also
Receptor/signaling modulators

.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;padding:0.2em 0;flex:0 0 auto;min-height:24px;line-height:22px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:baseline;flex:0 1 auto;padding:0.15em 0;column-gap:1em}.mw-parser-output .portal-bar-item{display:flex;align-items:baseline;margin:0.15em 0;min-height:24px;text-align:left}.mw-parser-output .portal-bar-logo{width:22px;line-height:22px;margin:0 0.2em;text-align:right}.mw-parser-output .portal-bar-link{margin:0 0.2em;text-align:left}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:baseline;flex:0;margin:0 auto;column-gap:1em;border-top:1px solid #a2a9b1}}.mw-parser-output .navbox+link+.portal-bar-bordered{margin-top:-1px}.mw-parser-output .navbox+style+.portal-bar-bordered{margin-top:-1px}.mw-parser-output .portal-bar+.navbox-styles+.navbox{margin-top:-1px}Portal:Medicine
Authority control General
Integrated Authority File (Germany)
National libraries
United States






